Growth hormone-releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan-induced chronic prostatitis.

Petra PopovicsRenzhi CaiWei ShaFerenc G RickAndrew V Schally

Published in: The Prostate (2018)

The study demonstrates that GHRH antagonists could be beneficial for the treatment of prostatic inflammation and BPH in part by inhibiting the growth-promoting and inflammatory effects of locally produced GHRH.

Keyphrases

benign prostatic hyperplasia
oxidative stress
growth hormone
lower urinary tract symptoms
diabetic rats
radical prostatectomy
drug induced
signaling pathway
high glucose
prostate cancer